Glutathione

Glutathione

Glutathione is the main antioxidant your body makes inside its own cells. It's a small protein (three amino acids: glutamate, cysteine, glycine) that sits in basically every cell you have, mopping up oxidative damage, recycling other antioxidants like vitamin C and E, and acting as the central tool your liver uses to neutralise toxins, drugs, alcohol, and metabolic waste. Most people who take it to support liver function, to dampen general oxidative stress as they age, or for skin tone and brightness.
The catch is that the form matters more than the dose. Swallowing a capsule of plain glutathione is inefficient because the gut breaks much of it down before it reaches your bloodstream. Liposomal glutathione, sublingual versions, and the precursor approach (NAC plus glycine, often called GlyNAC) all reliably raise body stores. Standard oral glutathione works too at high enough doses and over enough time, but it's the slowest route. Injectable forms (IV and IM) skip the gut entirely but carry real safety baggage and aren't necessary for most goals.

Deep-dive

Glutathione exists in two forms inside your cells: reduced (GSH), which is the active antioxidant, and oxidized (GSSG), which is what's left after GSH has neutralised something. The ratio of GSH to GSSG is one of the cleanest markers of cellular redox health you can measure. In a healthy young person, around 90-95% of total glutathione sits in the reduced form. As that ratio drops, you're looking at oxidative stress, and chronically low ratios track with aging, neurodegeneration, insulin resistance, liver disease, and most of the chronic conditions linked to mitochondrial dysfunction.
Your body makes glutathione from scratch in every cell, with the liver being the main producer. The rate-limiting step is cysteine availability, because glutamate and glycine are abundant but cysteine is the bottleneck. This is why NAC (N-acetylcysteine) works so reliably as a glutathione precursor, it delivers cysteine in a stable form. The enzyme that puts the first two amino acids together (gamma-glutamylcysteine synthetase, or GCL) is also rate-limited by feedback inhibition from glutathione itself, which is one reason simply pouring more substrate in doesn't push levels up indefinitely.
Does oral glutathione actually work? This was contested for decades. The classic argument was that intestinal enzymes break the tripeptide back into its constituent amino acids before it can be absorbed intact, which would make oral supplementation pointless. The 2015 Richie trial in the European Journal of Nutrition settled the question for standard oral glutathione, sort of. Over six months in 54 healthy adults, 1000 mg/day raised whole blood glutathione by around 30-35% in red blood cells, plasma, and lymphocytes, and 260% in buccal cells. Natural killer cell cytotoxicity doubled at three months in the high-dose group. Levels returned to baseline within a month after stopping. The 250 mg/day low dose still produced meaningful increases (17% in whole blood) but slower. So standard oral glutathione works, it's just slow and dose-dependent.
A 2018 trial of liposomal glutathione (500 or 1000 mg/day) hit similar endpoints faster: 40% increase in whole blood glutathione by week 2, 100% increase in peripheral blood mononuclear cells, and a 400% jump in NK cell cytotoxicity, all within four weeks. More recent crossover work in 2026 found micellar formulations push the GSH/GSSG ratio up faster than standard oral. The hierarchy is real: liposomal/micellar > standard oral > nothing, but standard oral isn't the dead end it was once made out to be.
The GlyNAC alternative. A separate research line out of Baylor College of Medicine has been making the case that the most effective way to raise glutathione is to give the body the building blocks. A 2021 pilot trial gave older adults glycine plus N-acetylcysteine for 16 weeks and found corrections in glutathione deficiency, oxidative stress, mitochondrial fuel oxidation, inflammation, insulin resistance, endothelial function, muscle strength, and cognition. A subsequent 36-week trial replicated and extended these findings, with cognitive improvements emerging at the longer timepoint. A separate 2022 RCT in 114 healthy older adults confirmed dose-dependent rises in whole blood glutathione at GlyNAC doses from 2.4 to 7.2 g/day. If you're taking glutathione for the broad anti-aging or mitochondrial angle, the GlyNAC approach has the strongest evidence in that specific population, and it's typically much cheaper than liposomal glutathione.
Liver and detoxification. This is glutathione's most established clinical use. The liver uses glutathione as the substrate for Phase II detoxification (glutathione conjugation), which is how it neutralises everything from acetaminophen metabolites to environmental toxins to alcohol byproducts. IV glutathione and NAC are the standard hospital treatment for acetaminophen overdose. A pilot trial in 34 NAFLD patients gave 300 mg/day of oral glutathione for 4 months after a lifestyle intervention period, and saw significant ALT reductions and improvements in liver fat measured by transient elastography. A 2025 review of three trials totaling 109 NAFLD patients found consistent improvements in ALT and oxidative stress markers like 8-OHdG, though all the trials were small.
Skin lightening. Glutathione inhibits tyrosinase, the enzyme that produces melanin, and it shifts melanin synthesis from darker eumelanin toward lighter pheomelanin. This is the basis for its enormous popularity as a skin-brightening agent, particularly across Asia. The evidence is real but modest. The 2010 Arjinpathana trial in 60 Thai adults showed 500 mg/day for 4 weeks reduced melanin index significantly at sun-exposed sites (face and forearm) compared to placebo, with no effect at sun-protected sites. The 2017 Weschawalit trial in healthy women found 250 mg/day of either reduced or oxidized glutathione for 12 weeks improved skin elasticity and reduced wrinkles, with both forms well tolerated. A 2019 systematic review concluded the evidence supports a brightening trend at sun-exposed sites but called the overall picture inconclusive due to small studies and inconsistent methods. Realistic expectation: subtle brightening of sun-exposed skin over 4-12 weeks, not dramatic depigmentation. Effects reverse when you stop.
Immune function. Both the Richie and Sinha trials showed substantial increases in natural killer cell cytotoxicity (2-fold and 4-fold respectively). Glutathione is essential for T-cell function, and chronically low glutathione is linked to immune senescence in older adults. The clinical translation of this is still emerging but the immune marker data is consistent.
Women. Most of the glutathione skin and aging trials have been conducted predominantly or exclusively in women. The Weschawalit trial was all-female. The Richie trial included roughly equal numbers. Glutathione interacts with oestrogen metabolism in a useful way: it conjugates the more reactive oestrogen metabolites (the catechol oestrogens, particularly 4-hydroxyestradiol) and helps clear them through Phase II liver detoxification. This matters because those reactive oestrogen metabolites can form DNA adducts if they're not detoxified efficiently. There's no evidence glutathione lowers oestrogen levels, it just helps you metabolise it cleanly. Women in perimenopause and menopause tend to have lower baseline glutathione, partly because oestrogen helps maintain glutathione synthesis, so this is a group where supplementation may have more room to work. Pregnancy and breastfeeding aren't well-studied for supplemental glutathione, default to skipping it.
The IV and IM question. Injectable glutathione produces the highest immediate blood levels of any route, which is why it's used clinically for acute conditions and why it's marketed heavily by drip clinics and aesthetic clinics for skin lightening and "detox." IV delivers the entire dose into the bloodstream in one go. IM is slower-release, the dose is deposited into muscle and absorbed over hours, which means lower peak blood levels but a longer tail and easier self-administration (which is why IM has become the more popular cosmetic route, especially in Southeast Asia where home-injection kits are widely sold). The actual evidence for elective injectable use is thin in both cases. The narrative review on glutathione for skin lightening flagged anaphylaxis, hepatotoxicity, severe skin reactions including Stevens-Johnson syndrome, and infection risk from non-sterile compounding as recurring problems with IV, particularly outside regulated medical settings. A 2018 dermatology review called the IV evidence base for skin lightening essentially a single flawed study and noted that IM is even less studied for cosmetic use, with most clinics extrapolating dosing from IV protocols without supporting trials. The Philippine FDA issued an explicit warning against IV glutathione for cosmetic use after multiple adverse event reports, and the same warning logic applies to IM in unregulated settings. The one peer-reviewed indication where IM has actual trial data is male infertility, a 1993 placebo-controlled crossover trial gave 600 mg IM every other day for 2 months and showed improvements in sperm motility and morphology in men with varicocele or genital tract inflammation. Outside that specific use case, the IM cosmetic protocols circulating online are clinician-extrapolated rather than trial-validated. If you're considering injectable glutathione for skin or wellness, the practical reality is most users get it from aesthetic clinics or compounding pharmacies, and product sterility, source quality, and injection technique matter as much as the dose itself.

Dosage:

  • Liposomal or micellar oral: 500-1000 mg/day. This is the most efficient practical route. Effects on glutathione stores typically show up within 2-4 weeks. Take on an empty stomach for best absorption. Brands matter, look for actual liposomal encapsulation rather than just the word on the label
  • Standard oral (Setria-grade): 250-1000 mg/day. Works but slower, expect 1-3 months for meaningful changes. The 1000 mg dose has the cleaner data
  • GlyNAC (precursor approach): 100 mg/kg/day each of glycine and N-acetylcysteine, divided into two doses. For a 70 kg person that's about 7 g of each per day, taken as 3.5 g morning and evening. This is the dose used in the Baylor trials and is most relevant if your goal is the broad anti-aging, mitochondrial, and metabolic angle rather than skin or acute liver support. Cheaper than liposomal glutathione by a wide margin
  • Skin brightening protocol: 250-500 mg/day oral glutathione, expect 4-12 weeks before noticing anything. Pairing with vitamin C (500-1000 mg) is common in published protocols and may modestly enhance the effect. Sun protection is non-negotiable, the brightening only shows up where UV isn't constantly stimulating new melanin production
  • Liver support during a heavy period: 500-1000 mg/day liposomal during periods of high alcohol intake, medication load, or known toxin exposure. Consider stacking with NAC at 600 mg twice daily
  • Older adults (60+): Both glutathione status and glutathione synthesis decline with age, and this group tends to respond well. The GlyNAC approach has the strongest evidence here. If using oral glutathione, run the higher end of doses (1000 mg liposomal)
  • Women in perimenopause and menopause: Same dosing as the general adult range, but this is a group where the underlying glutathione deficit is often more pronounced and benefits may be more noticeable. No specific dose adjustment needed
  • Forms that don't work well: S-acetyl glutathione is marketed as superior but pharmacokinetic data suggests it gets deacetylated rapidly and ends up indistinguishable from plain glutathione. Sublingual lozenges work reasonably well via oral mucosa absorption. Nebulised glutathione should be avoided unless you're working with a clinician for a specific lung condition (see side effects)
  • IV glutathione: 600-2400 mg per session, typically administered weekly or bi-weekly in clinical settings. Only worth considering for specific medical indications, not for general wellness. Sterile compounding and proper medical oversight are mandatory
  • IM glutathione: 600-1200 mg per injection, typical aesthetic clinic protocols run twice weekly for 4-12 weeks then drop to weekly or bi-weekly maintenance. Often paired with vitamin C 500-1000 mg either in the same syringe (if compounded together) or as a separate injection. Z-track or deep IM into the gluteal or deltoid muscle. The skin-brightening protocols circulating online are not trial-validated, expectations should match the modest effects seen in oral skin trials. The Lenzi infertility protocol of 600 mg every other day for 2 months is the only peer-reviewed IM dosing schedule for any non-skin indication. If you're going to use IM, source from a reputable compounding pharmacy with verifiable sterility documentation, not generic kits sold online. Avoid injecting product not labelled and intended for parenteral use, oral powders are not sterile and using them for injection is how serious infections happen

Here's what you can expect:

For most goals, glutathione is a slow-burn supplement, not something you feel from a single dose. Within 2-4 weeks of consistent liposomal use you may notice slightly clearer skin, less morning grogginess after drinking, and faster recovery from heavy days. The effects are subtle and easy to miss if you're not paying attention, which is why people often abandon it before it's had time to work.
For skin brightening specifically, the timeline is 4-12 weeks for visible changes, and only at sun-exposed sites. Don't expect dramatic depigmentation, expect a modest evening of tone and a slight overall brightness. The effect reverses within weeks of stopping, so it's a maintenance compound rather than a one-time intervention.
For liver support during heavy alcohol periods or medication courses, the subjective signal is usually "hangovers feel less brutal" and "I bounce back faster." Bloodwork (ALT, AST, GGT) is the more reliable signal if you actually want to verify it's doing something.
For the GlyNAC anti-aging protocol, the trials measured improvements over 16-36 weeks, and the most consistent subjective reports are improved energy, better recovery from exercise, and slight cognitive sharpness. This is not a stimulant or a peptide that produces dramatic week-one effects.
If you take it expecting to feel immediately different the next morning, you'll be disappointed. The compounds where you feel something acutely are stimulants and peptides. Glutathione is closer to a long-term system tune-up.

Side effects & risks:

  • GI side effects are the most common with oral forms: bloating, gas, loose stools, occasional nausea. Usually dose-dependent and resolves by lowering the dose or switching forms. Liposomal forms can be hit or miss because of the phosphatidylcholine carrier, some people tolerate it better than standard oral, others worse
  • Sulfur smell. Glutathione contains a thiol group, and you may notice a mild sulfur smell from the supplement, your breath, or your urine. Harmless but unpleasant. More noticeable with NAC than with glutathione itself
  • Asthma and inhaled glutathione. This is a real and serious caution. A 1997 trial in the American Journal of Respiratory and Critical Care Medicine showed nebulised glutathione caused major bronchoconstriction (FEV1 dropped 19%) in patients with mild asthma, with cough and breathlessness in most subjects. The proposed mechanism is sulfite formation from glutathione breakdown. Do not nebulise glutathione if you have asthma. Oral and topical forms are not implicated
  • Zinc depletion. Long-term high-dose glutathione has been associated with reduced zinc levels, presumably because glutathione conjugates with zinc and increases its excretion. If you're taking 1000 mg/day or more chronically, supplementing zinc (15-25 mg/day, ideally taken away from glutathione) is sensible
  • Injectable-specific risks (IV and IM). The narrative review on injectable glutathione catalogued anaphylaxis, hepatotoxicity, kidney stress, severe cutaneous reactions (including Stevens-Johnson syndrome and toxic epidermal necrolysis), and infection from non-sterile compounding. The Philippine FDA issued an explicit warning against IV glutathione for cosmetic use. IM carries lower risk of acute systemic reactions than IV because absorption is slower, but the infection and sterility risks are arguably worse because IM is more often self-administered with non-pharmacy product, leading to abscesses, cellulitis, and in rare cases sepsis. Repeated IM injection at the same site can also cause local muscle damage and persistent nodules. If you're not in a properly medicalised setting with a clear medical indication, injectable glutathione is the highest-risk route by a wide margin
  • Skin paradox (paradoxical hyperpigmentation). A subset of users on long-term oral or IV glutathione for skin lightening report worsening of pigmentation in some areas, sometimes patchy or uneven. Mechanism unclear. If you notice this, stop and reassess
  • Drug interactions. Glutathione's job is to conjugate and clear drugs, which means it can theoretically affect the metabolism of medications cleared via Phase II glutathione conjugation. The most clinically meaningful overlap is with chemotherapy drugs (where glutathione's protective effect on healthy cells may also reduce drug efficacy on cancer cells, oncology consensus is to discuss before using). Caution also if you're on acetaminophen at high chronic doses, on cisplatin, or on certain immunosuppressants
  • Pregnancy and breastfeeding. Insufficient safety data. Endogenous glutathione is essential during pregnancy but supplementation hasn't been adequately studied. Default to avoiding
  • The cancer question. Because glutathione protects cells from oxidative damage, there's a longstanding theoretical concern that supplementation could protect tumour cells from the very oxidative stress that chemotherapy and radiation rely on. Evidence is mixed and depends heavily on cancer type and treatment context. If you have an active cancer diagnosis, this is a conversation to have with your oncologist, not a decision to make from a supplement label
  • Long-term safety data. The 6-month Richie trial at 1000 mg/day showed no concerning safety signals. The 30-day micellar trial at 600 mg/day also showed clean liver and kidney panels. Beyond a year of continuous use, human data thins out
🩸

Blood markers

Whole blood GSH and GSH/GSSG ratio, baseline if you can access the test (not all standard labs offer it). Reference ranges vary by lab method, but a useful target is GSH around 900-1200 μmol/L in whole blood and a GSH/GSSG ratio above 100. Recheck at 3 months if you're using it specifically to correct a measured deficit. Most people taking glutathione for general purposes won't bother with this test, but it's the most direct readout of whether supplementation is actually moving the needle
Liver enzymes (ALT, AST, GGT), baseline before starting if you're taking glutathione for liver support or after a period of heavy alcohol or medication use. Recheck at 8-12 weeks. Improvements here are the most reliable objective signal that the liver-supportive use is working
Zinc, baseline if you plan to run 1000 mg/day or higher chronically. Long-term high-dose glutathione can deplete zinc. Recheck annually
CBC and immune markers are not standard but if you're taking glutathione specifically for immune support after illness or in older age, a simple CBC plus a vitamin D level gives a basic sense of immune system status
For most people taking glutathione for general antioxidant support, skin, or recovery, no specific bloodwork is needed before starting. The people who actually benefit from baseline testing are those with known liver issues, anyone over 60 considering chronic high-dose use, women in perimenopause specifically targeting glutathione deficiency, and anyone using IV protocols
Sold as a dietary supplement in most countries without prescription. Injectable glutathione (IV and IM) is regulated as a compounded medication in most jurisdictions and should only be administered with sterile, pharmacy-sourced product, ideally under medical supervision.